A cDNA clone for human catechol-Omethyltransferase (hCOMT; S-adenosyl-L-methionine:catechol O-methyltransferase; EC 2.1.1.6) was isolated from a human hepatoma cell line (Hep G2) cDNA library by hybridization screening with a porcine cDNA probe. The cDNA clone was sequenced and found to have an insert of 1226 nucleotides. The deduced primary structure of hCOMT is composed of 271 amino acid residues with the predicted molecular mass of 30 kDa. At its N terminus it has a hydrophobic segment of 21 amino acid residues that may be responsible for insertion of hCOMT into the endoplasmic reticulum membrane. The primary structure of hCOMT exhibits high homology to the porcine partial cDNA sequence (93%). The deduced amino acid sequence contains two tryptic peptide sequences ( Catechol-O-methyltransferase (COMT; S-adenosyl-L-methionine; catechol O-methyltransferase; EC 2.1.1.6) is an enzyme that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to the m-hydroxy group of catecholamine neurotransmitters (dopamine, noradrenaline, adrenaline), their metabolites, and L-dopa, thereby inactivating them. The enzyme has a broad substrate specificity accepting as substrate also catechol steroids, a-methyldopa, and apomorphine (1). It is widely distributed in various cerebral and extracerebral tissues of all mammalian species (2), including erythrocytes (3). The occurrence of at least two distinct isoforms of COMT has been demonstrated, of which one is soluble (S-COMT) and the other membrane-bound
Catechol-O-methyltransferase (COMT; S-adenosyl-L-methionine; catechol O-methyltransferase; EC 2.1.1.6) is an enzyme that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to the m-hydroxy group of catecholamine neurotransmitters (dopamine, noradrenaline, adrenaline), their metabolites, and L-dopa, thereby inactivating them. The enzyme has a broad substrate specificity accepting as substrate also catechol steroids, a-methyldopa, and apomorphine (1) . It is widely distributed in various cerebral and extracerebral tissues of all mammalian species (2), including erythrocytes (3) . The occurrence of at least two distinct isoforms of COMT has been demonstrated, of which one is soluble (S-COMT) and the other membrane-bound (MB-COMT) and whose relative abundance differs in various tissues and species. The biochemical characteristics of MB-COMT are less extensively investigated. This isoenzyme is localized in the microsomal fraction of different tissues, such as liver (4), brain (5) , erythrocytes (6) , and appears to be an integral membrane protein structurally distinct from the cytosolic S-COMT (7) . Although both forms of COMT catalyze the 0-methylation of catecholamines, MB-COMT has a much higher affinity for its substrates (6, 8) and might, therefore, contribute markedly to the metabolism of low concentrations of endogenous catecholamines in central nervous system and peripheral tissues.
Studies of COMT activity in erythrocytes suggest that individual variations are genetically determined. Data from segregation analysis provided evidence for the control of COMT activity by a major autosomal locus with two alleles (9) . Variations in COMT activity are found in patients with major depression, recurrent and bipolar disorders (10) , as well as in children with Down syndrome (11) . Differences in the enzymatic activity in human individuals may be involved in the pathogenesis of various psychiatric and neurological diseases (12) . To study the molecular genetics of these disorders, it is necessary to isolate the gene or genes coding for cytoplasmic and membrane-bound COMT.
In the present communication, we describe the molecular cloning of a cDNA encoding the human liver COMT. Se Isolation of Microsomes. After homogenization ofthe transfected 293 cells, a separation of the soluble from the membrane fraction was performed by differential centrifugation. The homogenate was centrifuged at 600 x g for 20 min, and the resulting supernatant was recentrifuged at 100,000 x g for 60 min. The pellet containing mitochondria and microsomes was washed twice and finally resuspended in 10 mM phosphate buffer, pH 7.6. The presence of recombinant hCOMT, both in the supernatant and in the pellet, was tested by immunoblotting (20) .
Soluble and membrane fractions from Hep G2 were obtained essentially as above.
RESULTS AND DISCUSSION
Protein Sequencing of Porcine Liver COMT. To obtain a partial amino acid sequence of COMT, we purified the soluble protein from porcine liver by using an immunoaffinity chromatography column (unpublished data). The highly purified protein was then subjected to tryptic digestion followed by purification of the tryptic peptides by HPLC. The sequences of two tryptic peptides, T-22: ILQYVLQPAVAGD-PQSVLDTIG and T-33: LLTIELNPDNAAIAQQVVDFA-GLQDWVTVVVGA, were determined by gas-phase microsequencing (22) .
Cloning of Porcine Liver COMT cDNA. A polyclonal antibody directed against highly purified porcine liver S-COMT was used to screen a Agtll cDNA expression library from porcine liver. In an initial immunoscreening, seven positive clones with inserts ranging between 1100 and 1300 base pairs (bp) were detected. The inserts of five of them crosshybridized to each other. The DNA sequences of the two largest crosshybridizing clones (1 and 7) contained an open reading frame coding for a protein of 186 amino acids with a predicted molecular mass of 20 kDa. The predicted amino acid sequences contained a stretch of 33 amino acids that matches perfectly with the porcine COMT tryptic peptide T-33 obtained by protein sequencing. This result strongly indicated that the isolated cDNA codes for a partial sequence of the porcine COMT.
Isolation and Sequence of hCOMT cDNA. Using the porcine COMT cDNA as hybridization probe, we isolated its human counterpart by screening a human cDNA library. Because (Fig. lb) .
To confirm the assigned initiator codon, a cRNA was synthesized in vitro by using the pSPI19 vector into which the hCOMT cDNA was subcloned. When either the partial porcine cDNA or AhCOMT F3 cDNA was used as hybridization probe (Fig. 2) .
Hydropathy and Secondary Structure of the Predicted Amino Acid Sequence of hCOMT. The results of the hydropathy index evaluation of hCOMT protein by the method of Kyte and Doolittle (25) are illustrated in Fig. 3 . According to these authors, any protein sequence corresponding to a membrane-spanning domain is characterized by a stretch of at least 18 amino acids exhibiting an average hydropathy index >1.6. In the hCOMT sequence, the N-terminal region (amino acids 6-26) meets these criteria, indicating that the hCOMT we cloned corresponds to the membrane-associated enzyme. Furthermore, the nature of the N-terminal region was investigated by using the criteria of Von Heijne (26) . The amino acids 1-28 of hCOMT contain a short negatively charged N-terminal region (amino acids 1-5), a 21-residuelong highly hydrophobic core (amino acids 6-26), and a positively charged C-terminal region. Such features are not characteristic of known eukaryotic signal peptides (27) but seem rather to belong to a class of N-terminal anchor segments, resulting in an N-terminally anchored protein with most of its mass exposed on the cytosolic face of the endoplasmic reticulum membrane.
Sequence Comparison. Comparison of the partial COMT sequence deduced from the porcine cDNA (amino acids with the deduced amino acid sequence of hCOMT (amino acid 86-271) (Fig. 4) shows high homology. The pCOMT: extent of sequence identity of hCOMT with porcine is 83%, but when the homology is calculated considering conservative amino acid substitutions, the figure is 93%. Nucleotide sequence homology between human and porcine COMT was found to be 83%. Seven cysteines are contained in the human sequence (Fig. lb) , of which at least four are conserved between the human and porcine enzyme (Fig. 4) .
Based on substantial evidence obtained by affinity-labeling studies, Borchardt (29) has suggested that two nucleophilic residues, probably sulfhydryl, exist at the active site of COMT and that both are necessary for enzymatic activity. We attempted to assign the active site in the predicted sequence of COMT. As indicated in Fig. 4 , a stretch of 71 amino acids (residues 79-150 of porcine and 164-235 of human sequences, respectively) is identical in the predicted sequences of both species. In particular, the two cysteines, separated by 15 amino acids, in the middle of the conserved stretch might be important for the catalytic activity ofCOMT. Further studies, such as site-directed mutagenesis, are needed to substantiate this assumption.
Transient Expression of hCOMT cDNA in 293 Cells. To confirm that the isolated cDNA indeed encodes hCOMT, the hCOMT F3 cDNA was subcloned into the eukaryotic expression vector pBC12/CMV (Fig. Sa) . 293 cells were transfected with the resultant construct, and COMT activity was measured in the cell homogenate. 293 cells contained very little endogenous enzyme activity, and this baseline level did not change after transfection with a plasmid lacking the hCOMT sequence. In contrast, 293 cells transfected with plasmid pBC12/CMV-hCOMT containing the entire hCOMT sequence showed a 20-fold increase in COMT activity (Fig. 5b) . The activity increased linearly as a function of the concentration of the homogenate and of the incubation time (15-90 min).
Inhibition of hCOMT Activity by Ro 40-7592. The effect of the two COMT inhibitors, Ro 40-7592 (3,4-dihydroxy-4'-methyl-5-nitrobenzophenone) and tropolone (2-hydroxy-2,4,6-cycloheptatrien-1-one) on recombinant hCOMT was investigated. Ro 40-7592 is a highly potent, competitive, and selective inhibitor and is presently under clinical trial for the therapy of Parkinson disease. This compound, used in combination with L-dopa and a peripheral decarboxylase inhibitor, is designed to prolong the duration of L-dopa action by preventing its conversion to 3-O-methyldopa (21) .
The inhibitory effect of Ro 40-7592 on the recombinant COMT activity was analyzed in the homogenate of cells transfected with the pBC12/CMV-hCOMT (Fig. 6 ). The recombinant enzyme was inhibited in a dose-dependent manner by Ro 40-7592 with an IC50 (-700 nM) found similar to that measured for the native enzyme in various animal tissues (21) . With tropolone, a relatively weak inhibitor of COMT, a 50% inhibition of recombinant COMT was observed at a concentration of '-4 clonal antibody (mAb) Co 60-1B/7. This antibody was raised against S-COMT from porcine liver and was shown to crossreact with human and rat COMT (unpublished data). A predominant immunoreactive band of 29-kDa apparent molecular mass and a weaker band of 25.5 kDa were detected (Fig. 7a) in the homogenates from transfected cells but not in the homogenates from untransfected cells.
To verify that the cDNA clone encodes the membraneassociated form of COMT, the homogenates from 293 cells transfected with plasmid pBC12/CMV-hCOMT were subjected to differential centrifugation. The resulting membrane and cytosolic fractions were tested by immunoblotting with mAb Co 60-1B/7 (Fig. 7b) . COMT immunoreactivity was found mostly in the membrane fraction, which indicates that the expressed hCOMT is incorporated mainly into the endoplasmic reticulum of 293 cells. The weaker immunoreactive band of 25.5 kDa was found in the cytosolic fraction. Fig. 7c shows an immunoblot of the cytosolic and membrane fractions from Hep G2 cell for comparison. This cell contains S-COMT and MB-COMT forms of the enzyme, which both react with mAb Co 60-1B/7. The molecular sizes of 29 kDa and 25.5 kDa observed for the recombinant COMT expressed in 293 cell are in good agreement with MB-COMT and S-COMT from Hep G2 cell.
These results suggest that the 25. --the membrane fraction.
The successful cloning of hCOMT will enable us to produce the enzyme in quantities needed for further structural 30 and functional analysis. Finally, we hope that the cDNA clone will provide valuable tools for the investigation not only 21 =, --of the cellular expression of COMT in various regions of the 4 brain but also of the genetic linkage of COMT alleles with 14.3 certain diseases of the central nervous system.
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